Internal Medicine, Pulmonary Disease · Olean, NY
NPI
1679970453
Since 2014
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
535 Main St Ste 1
Olean, NY, 14760
Phone (716) 372-0141
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
2,102 services
Medicare patients, 2024
435
Average age 74
Drug cost, 2024
$2.4M
5,139 prescriptions
Company payments, 2025
$3,488
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arthur Cacacho was code 94060 (pulmonary function testing), 424 times for 357 patients. In total Arthur Cacacho billed 2,102 services in 42 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94060 Pulmonary Function Testing | Office | 424 | 357 | $27.90 | $12K |
| 99214 Office E&M - Established | Office | 374 | 319 | $84.75 | $32K |
| 94726 Pulmonary Function Testing | Office | 273 | 251 | $38.62 | $11K |
| 94729 Pulmonary Function Testing | Office | 272 | 250 | $38.31 | $10K |
| 95012 Pulmonary | Office | 224 | 209 | $13.69 | $3,067 |
| 71046 X-ray - Chest | Office | 73 | 70 | $13.77 | $1,005 |
| 99291 Critical Care E&M | Facility | 69 | 33 | $154.43 | $11K |
| 99205 Office E&M - New | Office | 40 | 40 | $141.68 | $5,667 |
| 99215 Office E&M - Established | Office | 36 | 31 | $132.37 | $4,765 |
| 94618 Pulmonary Function Testing | Office | 22 | 21 | $25.65 | $564 |
| 36415 Venipuncture Blood Collection | Office | 20 | 12 | $8.65 | $173 |
| 94010 Pulmonary Function Testing | Office | 20 | 19 | $19.77 | $395 |
| 71250 CT/CTA - Chest | Office | 17 | 17 | $52.31 | $889 |
| 99292 Critical Care E&M | Facility | 16 | 14 | $80.04 | $1,281 |
| 71271 CT/CTA - Chest | Office | 12 | 12 | $83.30 | $1,000 |
By year: 2022 $143K for 3,407 services; 2023 $110K for 2,328 services; 2024 $99K for 2,102 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 12 | $8.65 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Arthur Cacacho prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 977 prescriptions and refills. In total Arthur Cacacho wrote 5,139 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 977 | 1,172 | 212 | $736K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 867 | 992 | 262 | $28K |
| Azithromycin Generic | 651 | 753 | 179 | $5,265 |
| Roflumilast Generic | 427 | 569 | 86 | $33K |
| Prednisone Generic | 340 | 364 | 138 | $1,659 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 223 | 249 | 48 | $149K |
| Breo Ellipta Fluticasone/Vilanterol | 200 | 251 | 42 | $98K |
| Montelukast Sodium Generic | 197 | 452 | 56 | $2,027 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 121 | 163 | 24 | $74K |
| Spiriva Respimat Tiotropium Bromide | 101 | 148 | 31 | $75K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 91 | 119 | 25 | $15K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 86 | 102 | 24 | $18K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 80 | 106 | 16 | $49K |
| Incruse Ellipta Umeclidinium Bromide | 75 | 91 | 15 | $30K |
| Symbicort Budesonide/Formoterol Fumarate | 63 | 111 | 25 | $23K |
Brand drugs: 2,604 claims; generic drugs: 2,535 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arthur Cacacho $3,488 ($3,488 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $733.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 28 | $733 |
| GlaxoSmithKline, LLC. GSK | 39 | $522 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $365 |
| Mallinckrodt Hospital Products Inc. | 6 | $251 |
| Genzyme Corporation SNY | 12 | $249 |
| Viatris Specialty LLC | 8 | $195 |
| Insmed, Inc. INSM | 20 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $125 |
| Amgen Inc. AMGN | 5 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.